Firstsource tanks 16% in 2 days after Q1 show; brokerages mixed on outlook

Firstsource Solutions shares fell more than 16% over two sessions after its Q1FY27 results. Net profit declined 2% to ₹165.92 crore, while revenue rose 23.9% YoY to ₹2,751.75 crore. Nomura kept a Buy rating, raised target to ₹310, and revised FY27-FY28 EPS estimates. Emkay raised its target to ₹270 but downgraded to Reduce.

Original reporting
Published Aug 10, 2026, 12:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 12:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Firstsource tanks 16% in 2 days after Q1 show; brokerages mixed on outlook — source image
Decision brief

The 30-second read

$FSOLBearishMed
01

Why it matters

Net profit declined slightly while revenue grew strongly YoY; brokerages differed on outlook, with Nomura keeping Buy and raising target, while Emkay cut to Reduce citing limited near-term upside after recent returns.

02

Market read

A fresh earnings print with guidance confirmation and a vertical contract termination is being interpreted as insufficient to justify the stock’s recent run, driving a rapid de-rating.

03

What to watch

The article notes Healthcare contract termination due to client leadership change; traders may be underweighting how quickly new wins offset churn, and overemphasizing short-term EPS estimate revisions versus guidance durability.

Relevance 7/10Novelty 6/10Timing: post-Q1FY27 release, during the following two trading sessions

Background

Firstsource Solutions reported Q1FY27 (Apr-Jun 2026) results, then the stock sold off sharply over the next two sessions.

Company-level read

Ticker impact

$FSOLBearishMedium confidence
Context

Firstsource Solutions shares fell over 16% in two sessions after its Q1FY27 results, with net profit down 2% and revenue up 23.9% YoY.

Expected impact

Bearish near term, with volatility likely to persist until investors digest the Healthcare contract termination and FY27 constant-currency growth guidance.

Evidence & confidence

The article ties the selloff to the Q1FY27 release and highlights a contract termination in Healthcare, while only partially offsetting it with deal wins and retained FY27 CC growth guidance; brokerages adjust EPS estimates and targets but differ on rating changes.

Market effects

Signals investor sensitivity to BFS/Telecom and Media growth versus client churn in Healthcare for IT services/operations outsourcing peers.

May weigh on India mid-cap IT services sentiment given the large single-name drawdown tied to earnings.

Limited direct global read-through, but Europe and constant-currency growth commentary could influence cross-region IT services positioning.

Counterpoint

The company retained FY27 constant-currency revenue growth guidance (10-13%) and added multiple large deals and new logos, suggesting the selloff may over-discount execution noise from one vertical.

Key entities

  • Firstsource Solutions Ltd.

    Subject of the article; shares dropped after Q1FY27 results, with revenue up YoY and net profit down slightly.

  • Nomura

    Maintained positive growth view, kept Buy, raised target to ₹310, and revised FY27-FY28 EPS estimates up 2-5%.

  • Emkay

    Raised target to ₹270 but downgraded to Reduce, citing limited near-term upside after strong recent returns.

Related articles

$UNFIMedAI 8/10

United Natural Foods (UNFI) Calls the Bottom and Guides for Growth Again

United Natural Foods (UNFI) reported Q4 adjusted EPS of $0.69, beating estimates, but revenue of $7.64B missed expectations. The company guided fiscal 2027 sales to $31.2B-$31.8B, up from $31.15B in 2026. Adjusted EBITDA rose 27% to $701M, and free cash flow hit a record $323M. Management expects fiscal 2027 adjusted EPS of $3.00-$3.50. Hedge fund interest declined in Q2.

MedAI 8/10

LuxExperience B.V. Q4 2026 Earnings Call Summary

LuxExperience B.V. reported Q4 2026 earnings, highlighting EBITDA break-even 15 months post-acquisition. Mytheresa reached EUR 1 billion in sales, while NET-A-PORTER and MR PORTER returned to growth. YOOX cut losses by half. Management expects 2%-3% EBITDA margins in FY 2027 and EUR 4 billion in net sales by 2028. The company improved operational efficiency and strengthened its financial position.

$MOVMed

Movado’s Turnaround Gains Momentum

Movado Group (NYSE: MOV) reported two consecutive quarters of earnings beats, with shares up 60% year-to-date. Analysts rate it a Strong Buy, with an average price target of $40, implying 22% upside. The company benefited from tariff refunds and a shift in consumer preferences toward traditional watches. However, investors should consider potential margin pressures and competition from smartwatches.